Suchergebnisse
Suchergebnisse:
Vor einem Tag · Representatives Lisa Blunt Rochester and Larry Bucshon introduced the bill, neither of whom has a previous record on blockchain or crypto issues. On Dec. 5, the House Committee on Energy and ...
Vor 5 Tagen · WASHINGTON – On Wednesday, Congressman Larry Bucshon, M.D. (R-IN-08) and Congressman Raul Ruiz, M.D. (D-CA-25) introduced bipartisan legislation (H.R. 8412) to improve participation in clinical trials by underrepresented populations. The Clinical Trial Modernization Act builds on the successes of clinical trials legislation passed ...
Vor 9 Stunden · The bill was introduced by Representatives Lisa Blunt Rochester and Larry Bucshon, neither of whom had a prior record on blockchain or crypto issues. On December 5, the House Committee on Energy and Commerce unanimously approved the bill. It has received endorsements from notable industry groups such as the Chamber of Digital Commerce and the Blockchain Association.
Vor 4 Tagen · Source: United States House of Representatives – Representative Larry Bucshon MD (R-Ind) WASHINGTON – On Wednesday, Congressman Larry Bucshon, M.D. (R-IN-08) and Congressman Raul Ruiz, M.D. (D-CA-25) introduced bipartisan legislation (H.R. 8412) to improve participation in clinical trials by underrepresented populations.
Vor 3 Tagen · On May 7, nearly 100 rheumatologists and rheumatology professionals converged in Washington, D.C., for the ACR’s annual Advocacy Leadership Conference (ALC). Rep. Larry Bucshon, MD, with ACR President Deborah Dyett Desir, MD, and Government Affairs Committee Chair Christina Downey, MD. Over the two-day conference, attendees from the ACR’s ...
Vor einem Tag · Congressmen Larry Bucshon said, “It became clear to me over the Christmas holiday … that the time has come to bring my season in public service to a conclusion.” Rep. Blaine Luetkemeyer and Rep. Doug Lamborn also announced their retirements.
Vor 5 Tagen · Sponsored by Reps. Raul Ruiz (D-Calif.) and Larry Bucshon (R-Ind.), the Clinical Trial Modernization Act is bipartisan legislation that would increase access to clinical trials by helping remove cost and geographic barriers to patient participation.
